▶ 調査レポート

世界の抗体受託製造市場

• 英文タイトル:Market Study on Antibodies Contract Manufacturing: Monoclonal Antibodies to Dominate Market Share by Far

Market Study on Antibodies Contract Manufacturing: Monoclonal Antibodies to Dominate Market Share by Far「世界の抗体受託製造市場」(市場規模、市場予測)調査レポートです。• レポートコード:PMR2201A047
• 出版社/出版日:Persistence Market Research / 2021年10月25日
• レポート形態:英文、PDF、220ページ
• 納品方法:Eメール
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥622,300 (USD4,900)▷ お問い合わせ
  Site Licence¥965,200 (USD7,600)▷ お問い合わせ
  Enterprisewide¥1,346,200 (USD10,600)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
Persistence Market Research社の本調査レポートは、世界の抗体受託製造市場について調査し、エグゼクティブサマリー、市場概要、主要インクルージョン、主要成功要因、市場背景、新型コロナウイルス感染症の影響分析、市場需要分析/予測、製品別(モノクローナル抗体、抗体フラグメントン、ポリクローナル抗体)分析、発現別(哺乳類、微生物)分析、企業規模別(小型、中型、大型、超大型)分析、運用別(前臨床、臨床、商業)分析、地域別分析、主要国分析、市場構造分析、競争分析、仮定、調査手法などを掲載しています。
・エグゼクティブサマリー
・市場概要
・主要インクルージョン
・主要成功要因
・市場背景
・新型コロナウイルス感染症の影響分析
・市場需要分析/予測
・世界の抗体受託製造市場規模:製品別(モノクローナル抗体、抗体フラグメントン、ポリクローナル抗体)
・世界の抗体受託製造市場規模:発現別(哺乳類、微生物)
・世界の抗体受託製造市場規模:企業規模別(小型、中型、大型、超大型)
・世界の抗体受託製造市場規模:運用別(前臨床、臨床、商業)
・世界の抗体受託製造市場規模:地域別
・主要国分析
・市場構造分析
・競争分析
・仮定
・調査手法

Antibodies Contract Manufacturing Market- Scope of Report

The latest publication by Persistence Market Research on the antibodies contract manufacturing market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2021-2031.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research’s study. This research study can support readers to know the demand for antibodies contract manufacturing market and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the antibodies contract manufacturing market. The insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the antibodies contract manufacturing market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibodies contract manufacturing market are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments
Persistence Market Research’s study on the antibodies contract manufacturing market offers information divided into five important segments – product, expression system, company size, scale of operation, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
Monoclonal Antibodies
Antibody Fragments
Polyclonal Antibodies

Expression System
Mammalian
Microbial
Bacteria
Yeast

Company Size
Small
Mid-sized
Large
Very large

Scale of Operation
Preclinical
Clinical
Commercial

Region
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)

Key Questions Answered in Report
Which regions will continue to remain the most profitable markets for antibodies contract manufacturing market over the coming years?
How will changing trends impact the market?
How has the COVID-19 crisis impacted market growth?
How can market players capture the low-hanging opportunities in developed regions?
What are the strategies of stakeholders in the market to shape their position in this landscape?
What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
What are the developmental trends that will impact the market?
How can companies in the antibodies contract manufacturing industry avail themselves the growth opportunities in developed and emerging sectors?

Research Methodology
In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the antibodies contract manufacturing market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the antibodies contract manufacturing market more accurate and reliable.

レポート目次

1. Executive Summary

1.1. Global Market Outlook

1.2. Key Market Trends

1.3. Market Analysis & Recommendation

2. Market Overview

2.1 Market Coverage/Taxonomy

2.2 Market Definition/Scope

2.3 Inclusions/Exclusions

3. Key Inclusions

3.1. Key Trends Impacting the Market

3.2. Product Innovation/ Development Trends

4. Key Success Factors

4.1. Product Adoption/Usage Analysis

4.2. List of Trading Companies in China and India

4.3. List of Local Manufacturers and their Distribution Strategy/Locations

4.4. Key Regulatory Scenario

4.5. Value Chain Analysis

5. Market Background

5.1. Macro-Economic Factors

5.1.1. Global GDP Outlook

5.1.2. Global Healthcare Outlook

5.1.3. Global Healthcare Expenditure Outlook

5.2. Forecast Factors – Relevance & Impact

5.2.1. Increasing number of healthcare facilities

5.2.2. Emergence of new infectious diseases

5.2.3. Rise in disposable income

5.2.4. Key players historic growth

5.2.5. New product approval/launches

5.2.6. Growing popularity of healthcare check-ups

5.2.7. Product Adoption

5.2.8. Rise in Prevalence of chronic and lifestyle disease

5.2.9. Key Strategic developments

5.3. Market Dynamics

5.3.1. Drivers

5.3.2. Restraints

5.3.3. Opportunities

6. COVID-19 Crisis Impact Analysis

6.1.1. Current COVID-19 perspective and Probable Impact

6.1.2. Current GDP Projections and Probable Impact

6.1.3. COVID-19 Crisis Analysis- Overview

6.1.4. COVID-19 Crisis Impact –Global

6.1.5. COVID-19 Crisis Impact on Antibodies Contract Manufacturing Market

7. Global Antibodies Contract Manufacturing Market Demand Value (Size US$ Mn) Analysis, By Product,2016-2020 and Forecast 2021-2031

7.1. Historical Market Value (US$ Mn) Analysis. 2016-2020

7.2. Current and Future Market Value (US$ Mn) Projections, 2021-2031

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Global Antibodies Contract Manufacturing Market and Volume Analysis 2016-2020 and Forecast, 2021-2031, By Product

8.1. Introduction / Key Findings

8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2020

8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2021 – 2031

8.3.1. Monoclonal Antibodies

8.3.2. Antibody Fragments

8.3.3. Polyclonal Antibodies

8.4. Market Attractiveness Analysis By Product

9. Global Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031, By Expression System

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) Analysis By Expression System, 2016-2020

9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Expression System, 2021-2031

9.3.1. Mammalian

9.3.2. Microbial

9.3.2.1. Bacteria

9.3.2.2. Yeast

9.4 Market Attractiveness Analysis By Expression System

10. Global Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031, By Company Size

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) Analysis By Company Size, 2016-2020

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Company Size, 2021-2031

10.3.1. Small

10.3.2. Mid-Sized

10.3.3. Large

10.3.4. Very large

10.4. Market Attractiveness Analysis By Company Size

11. Global Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031, By Scale of Operation

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Scale of Operation, 2016-2020

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Scale of Operation, 2021-2031

11.3.1. Preclinical

11.3.2. Clinical

11.3.3. Commercial

11.4 Market Attractiveness Analysis By Company Size

12. Global Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031, By Region

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2020

12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2021-2031

12.3.1. North America

12.3.2. Latin America

12.3.3. Europe

12.3.4. East Asia

12.3.5. South Asia

12.3.6. Oceania

12.3.7. Middle East and Africa (MEA)

12.4. Market Attractiveness Analysis By Region

13. North America Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

13.3.1. By Country

13.3.1.1. U. S.

13.3.1.2. Canada

13.3.2. By Product

13.3.3. By Expression System

13.3.4. By Company Size

13.3.5. By Scale of Operation

13.4. Market Attractiveness Analysis

13.5. Key Market Participants – Intensity Mapping

13.6. Drivers and Restraints – Impact Analysis

14. Latin America Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

14.3.1. By Country

14.3.1.1. Brazil

14.3.1.2. Mexico

14.3.1.3. Argentina

14.3.1.4. Rest of Latin America

14.3.2. By Product

14.3.3. By Expression System

14.3.4. By Company Size

14.3.5. By Scale of Operation

14.4. Market Attractiveness Analysis

14.5. Key Market Participants – Intensity Mapping

14.6. Drivers and Restraints – Impact Analysis

15. Europe Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

15.3.1. By Country

15.3.1.1. Germany

15.3.1.2. Italy

15.3.1.3. France

15.3.1.4. U. K.

15.3.1.5. Spain

15.3.1.6. BENELUX

15.3.1.7. Russia

15.3.1.8. Rest of Europe

15.3.2. By Product

15.3.3. By Expression System

15.3.4. By Company Size

15.3.5. By Scale of Operation

15.4. Market Attractiveness Analysis

15.5. Key Market Participants – Intensity Mapping

15.6. Drivers and Restraints – Impact Analysis

16. South Asia Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031

16.1 Introduction

16.2 Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

16.3 Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

16.3.1. By Country

16.3.1.1. India

16.3.1.2. Thailand

16.3.1.3. Indonesia

16.3.1.4. Malaysia

16.3.1.5. Rest of South Asia

16.3.2. By Product

16.3.3. By Expression System

16.3.4. By Company Size

16.3.5. By Scale of Operation

16.4. Market Attractiveness Analysis

16.5. Key Market Participants – Intensity Mapping

16.6. Drivers and Restraints – Impact Analysis

17. East Asia Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031

17.1 Introduction

17.2 Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

17.3 Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

17.3.1. By Country

17.3.1.1. China

17.3.1.2. Japan

17.3.1.3. South Korea

17.3.2. By Product

17.3.3. By Expression System

17.3.4. By Company Size

17.3.5. By Scale of Operation

17.4. Market Attractiveness Analysis

17.5. Key Market Participants – Intensity Mapping

17.6. Drivers and Restraints – Impact Analysis

18. Oceania Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031

18.1. Introduction

18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

18.3.1. By Country

18.3.1.1. Australia

18.3.1.2. New Zealand

18.3.2. By Product

18.3.3. By Expression System

18.3.4. By Company Size

18.3.5. By Scale of Operation

18.4. Market Attractiveness Analysis

18.5. Key Market Participants – Intensity Mapping

18.6. Drivers and Restraints – Impact Analysis

19. Middle East and Africa Antibodies Contract Manufacturing Market Analysis 2016-2020 and Forecast, 2021-2031

19.1. Introduction

19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2020

19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2021-2031

19.3.1. By Country

19.3.1.1. GCC Countries

19.3.1.2. South Africa

19.3.1.3. Rest of Middle East and Africa

19.3.2. By Product

19.3.3. By Expression System

19.3.4. By Company Size

19.3.5. By Scale of Operation

19.4. Market Attractiveness Analysis

19.5. Key Market Participants-Intensity Mapping

19.6. Drivers and Restraints-Impact Analysis

20. Key and Emerging Countries Antibodies Contract Manufacturing Market Analysis 2021 & 2031

20.1. Introduction

20.1.1. Market Value Proportion Analysis, By Key Countries

20.1.2. Global Vs. Country Growth Comparison

20.2. U. S. Antibodies Contract Manufacturing Market Analysis

20.2.1. By Product

20.2.2. By Expression System

20.2.3. By Company Size

20.2.4. By Scale of Operation

20.3. Canada Antibodies Contract Manufacturing Market Analysis

20.3.1. By Product

20.3.2. By Expression System

20.3.3. By Company Size

20.3.4. By Scale of Operation

20.4. Mexico Antibodies Contract Manufacturing Market Analysis

20.4.1. By Product

20.4.2. By Expression System

20.4.3. By Company Size

20.4.4. By Scale of Operation

20.5. Brazil Antibodies Contract Manufacturing Market Analysis

20.5.1. By Product

20.5.2. By Expression System

20.5.3. By Company Size

20.5.4. By Scale of Operation

20.6. U. K. Antibodies Contract Manufacturing Market Analysis

20.6.1. By Product

20.6.2. By Expression System

20.6.3. By Company Size

20.6.4. By Scale of Operation

20.7. Germany Antibodies Contract Manufacturing Market Analysis

20.7.1. By Product

20.7.2. By Expression System

20.7.3. By Company Size

20.7.4. By Scale of Operation

20.8. France Antibodies Contract Manufacturing Market Analysis

20.8.1. By Product

20.8.2. By Expression System

20.8.3. By Company Size

20.8.4. By Scale of Operation

20.9. Italy Antibodies Contract Manufacturing Market Analysis

20.9.1. By Product

20.9.2. By Expression System

20.9.3. By Company Size

20.9.4. By Scale of Operation

20.10. Spain Antibodies Contract Manufacturing Market Analysis

20.10.1. By Product

20.10.2. By Expression System

20.10.3. By Company Size

20.10.4. By Scale of Operation

20.11. BENELUX Antibodies Contract Manufacturing Market Analysis

20.11.1. By Product

20.11.2. By Expression System

20.11.3. By Company Size

20.11.4. By Scale of Operation

20.12. Russia Antibodies Contract Manufacturing Market Analysis

20.12.1. By Product

20.12.2. By Expression System

20.12.3. By Company Size

20.12.4. By Scale of Operation

20.13. China Antibodies Contract Manufacturing Market Analysis

20.13.1. By Product

20.13.2. By Expression System

20.13.3. By Company Size

20.13.4. By Scale of Operation

20.14. Japan Antibodies Contract Manufacturing Market Analysis

20.14.1. By Product

20.14.2. By Expression System

20.14.3. By Company Size

20.14.4. By Scale of Operation

20.15. South Korea Antibodies Contract Manufacturing Market Analysis

20.15.1. By Product

20.15.2. By Expression System

20.15.3. By Company Size

20.15.4. By Scale of Operation

20.16. India Antibodies Contract Manufacturing Market Analysis

20.16.1. By Product

20.16.2. By Expression System

20.16.3. By Company Size

20.16.4. By Scale of Operation

20.17. ASEAN Antibodies Contract Manufacturing Market Analysis

20.17.1. By Product

20.17.2. By Expression System

20.17.3. By Company Size

20.17.4. By Scale of Operation

20.18. Australia Antibodies Contract Manufacturing Market Analysis

20.18.1. By Product

20.18.2. By Expression System

20.18.3. By Company Size

20.18.4. By Scale of Operation

20.19. New Zealand Antibodies Contract Manufacturing Market Analysis

20.19.1. By Product

20.19.2. By Expression System

20.19.3. By Company Size

20.19.4. By Scale of Operation

20.20. GCC Countries Antibodies Contract Manufacturing Market Analysis

20.20.1. By Product

20.20.2. By Expression System

20.20.3. By Company Size

20.20.4. By Scale of Operation

20.21. Turkey Antibodies Contract Manufacturing Market Analysis

20.21.1. By Product

20.21.2. By Expression System

20.21.3. By Company Size

20.21.4. By Scale of Operation

20.22. South Africa Antibodies Contract Manufacturing Market Analysis

20.22.1. By Product

20.22.2. By Expression System

20.22.3. By Company Size

20.22.4. By Scale of Operation

21. Market Structure Analysis

21.1. Market Analysis By Tier of Companies

21.2. Market Share Analysis By Key Players

22. Competition Analysis

22.1.1. AMRI

22.1.1.1. Product Type Portfolio

22.1.1.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.1.1.2. Sales Footprint

22.1.1.1.3. Analyst commentary

22.1.2. AGC Biologics

22.1.2.1. Product Type Portfolio

22.1.2.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.2.1.2. Sales Footprint

22.1.2.1.3. Analyst commentary

22.1.3. Aldevron

22.1.3.1. Product Type Portfolio

22.1.3.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.3.1.2. Sales Footprint

22.1.3.1.3. Analyst commentary

22.1.4. Eurofins CDMO

22.1.4.1. Product Type Portfolio

22.1.4.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.4.1.2. Sales Footprint

22.1.4.1.3. Analyst commentary

22.1.5. Boehringer Ingelheim BioXcellence

22.1.5.1. Product Type Portfolio

22.1.5.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.5.1.2. Sales Footprint

22.1.5.1.3. Analyst commentary

22.1.6. FUJIFILM Diosynth Biotechnologies

22.1.6.1. Product Type Portfolio

22.1.6.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.6.1.2. Sales Footprint

22.1.6.1.3. Analyst commentary

22.1.7. Emergent BioSolutions

22.1.7.1. Product Type Portfolio

22.1.7.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.7.1.2. Sales Footprint

22.1.7.1.3. Analyst commentary

22.1.8. KBI Biopharma

22.1.8.1. Product Type Portfolio

22.1.8.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.8.1.2. Sales Footprint

22.1.8.1.3. Analyst commentary

22.1.9. Lonza

22.1.9.1. Product Type Portfolio

22.1.9.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.9.1.2. Sales Footprint

22.1.9.1.3. Analyst commentary

22.1.10. Novasep

22.1.10.1. Product Type Portfolio

22.1.10.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.10.1.2. Sales Footprint

22.1.10.1.3. Analyst commentary

22.1.11. Nitto Avecia Pharma Services

22.1.11.1. Product Type Portfolio

22.1.11.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.11.1.2. Sales Footprint

22.1.11.1.3. Analyst commentary

22.1.12. Pierre Fabre

22.1.12.1. Product Type Portfolio

22.1.12.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.12.1.2. Sales Footprint

22.1.12.1.3. Analyst commentary

22.1.13. Samsung BioLogics

22.1.13.1. Product Type Portfolio

22.1.13.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.13.1.2. Sales Footprint

22.1.13.1.3. Analyst commentary

22.1.14. Synthon

22.1.14.1. Product Type Portfolio

22.1.14.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.14.1.2. Sales Footprint

22.1.14.1.3. Analyst commentary

22.1.15. Thermo Fisher Scientific.

22.1.15.1. Product Type Portfolio

22.1.15.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.15.1.2. Sales Footprint

22.1.15.1.3. Analyst commentary

22.1.16. AbbVie, Inc.

22.1.16.1. Product Type Portfolio

22.1.16.1.1. Profitability by Market Segments (Drug Class/Distribution Channel/Region)

22.1.16.1.2. Sales Footprint

22.1.16.1.3. Analyst commentary

23. Assumptions & Acronyms

24. Research Methodology

Table 01: Global Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 02: Global Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 03: Global Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 04: Global Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 05: Global Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 06: Global Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Region

Table 07: North America Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 08: North America Antibodies Contract Manufacturing Market Size (Usman) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 09: North America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 10: North America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 11: North America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 12: North America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 13: Latin America Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 14: North America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 15: North America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 16: Latin America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 17: Latin America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 18: Latin America Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 19: Europe Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 20: Europe Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 21: Europe Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 22: Europe Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 23: Europe Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 24: Europe Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 25: South Asia Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 26: South Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 27: South Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 28: South Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 29: South Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 30: South Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 31: East Asia Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 32: East Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 33: East Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 34: East Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 35: East Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 36: East Asia Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 37: Oceania Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 38: Oceania Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 39: Oceania Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 40: Oceania Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 41: Oceania Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 42: Oceania Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country

Table 43: MEA Antibodies Contract Manufacturing Market Volume (Mn ) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 44: MEA Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Product

Table 45: MEA Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Expression System

Table 46: MEA Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Company Size

Table 47: MEA Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Scale of Operation

Table 48: MEA Antibodies Contract Manufacturing Market Size (US$ Mn) Analysis 2016-2020 and Forecast 2021-2031, By Country